This study evaluates and compares three anti-Hepatitis C Virus antibody tests using chemiluminescence and enzyme-linked immunosorbent assay methods for diagnosing Hepatitis C in Turkey. The research assesses the accuracy, reliability, and performance of these tests, providing valuable insights for improving diagnostic practices. The findings offer a comprehensive comparison, helping healthcare professionals select the most effective test for accurate Hepatitis C diagnosis, ultimately enhancing patient care and treatment outcomes.
In Turkey, the accurate diagnosis of hepatitis C virus (HCV) infections relies heavily on the performance of antibody tests, particularly those employing chemiluminescence and enzyme-linked immunosorbent assay (ELISA) methodologies. A study conducted and published on ResearchGate evaluates and compares three distinct anti-HCV antibody tests, analyzing their diagnostic accuracy and reliability for detecting HCV infections. This research provides critical insights into the effectiveness of these assays in contributing to the early and precise identification of hepatitis C, thereby informing clinical practice and improving public health outcomes in Turkey.
